Medicare beneficiaries could save more than $1 billion in copayments on prescription drugs in 2027 under new drug pricing guidelines proposed by the federal government on July 2.
The proposed rules would significantly narrow a loophole allowing major hospital chains to cash in on mandatory prescription drug discounts intended for struggling, safety-net providers.
The provision is part of the 340B Drug Pricing Program, which Congress created to a…